AzTrials
AzTrials

StressNCT00468572

Using Affectionate Communication as a Response to Acute Stress

A study testing Affectionate Writing and Meaningless Writing in people with Stress, run by Arizona State University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will examine the effects of tending to significant social relationships on managing and reducing stress. Read more about this study

Who is it for?
Ages 18 to 75 yearsHealthy volunteers can take part
Conditions the study is for
Stress
What is being tested?
Affectionate Writing and Meaningless Writing
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteUnited States
Study dates
Feb 2007to Dec 2007
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • English-speaking
  • Weigh at least 110 pounds
  • Moderate to no anxiety about having blood drawn

Who cannot join

  • Hypertension or diabetes
  • Current or recent pregnancy
  • Colorblindness
  • History of cancer
  • Current use of alpha blockers, beta blockers, or steroids

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Exercise and Sports Research Institute

    Tempe, Arizona, 85287

Other trials in United States

About this study

Official title: Affectionate Communication as a Mechanism for Responding to Acute Stress

This study will examine the effects of tending to significant social relationships on managing and reducing stress.

Read the detailed description

Stress is a large part of daily modern life; however, it can cause a number of long-term problems for mental and physical health. Recent research has confirmed that there are definite mental and physical health benefits of maintaining significant positive social bonds. Many of these benefits appear to be associated with the ability to regulate stress that is caused by environmental challenges. Drawing on close relationships and expressing affection may help people to recover from stress more effectively. This study will evaluate the tend-and-befriend theory, which suggests that engaging in behaviors aimed at maintaining and strengthening significant social bonds can act as an adaptive response to acute stress.

All participants in this study will undergo a series of standard laboratory stressors designed to elevate cortisol levels. Cortisol, also known as the "stress hormone," is activated and secreted within the body in response to stress. Current research suggests that displaying signs of affection toward a loved one can lower cortisol levels, causing the body to relax and recover from a stressful situation more quickly. After lab tests have been completed, participants will be randomly assigned to an experimental or control group. Participants assigned to the experimental group will spend 20 minutes writing an affectionate letter to a loved one. Participants assigned to the control group will spend 20 minutes writing about meaningless topics. Levels of cortisol will be measured using saliva samples from each participant during the writing session. Levels of oxytocin, a hormone known to transmit signals within the brain and often associated with bonding and building trusting relationships, will be measured from blood samples taken during the writing session as well. Participants will also provide a self-report of their current stress level at the end of the study. Participation in this study will last approximately 2 hours. By examining associations between the communication of affection and responses to acute stress, this study may eventually lead to the development of new and better treatment options for people with constant acute stress.

Conditions
Stress
Being tested
Affectionate Writing, Meaningless Writing
Keywords
Emotion, Oxytocin, Cortisol

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Affectionate WritingBehavioural

    Participants assigned to the experimental group will spend 20 minutes writing an affectionate letter to a loved one. Levels of cortisol will be measured using saliva samples from each participant during the writing session. Levels of oxytocin, a hormone known to transmit signals within the brain and often associated with bonding and building trusting relationships, will be measured from blood samples taken during the writing session as well.

  • Meaningless WritingBehavioural

    Participants assigned to the control group will spend 20 minutes writing about meaningless topics. Participants will undergo the same testing during the writing session as the experimental group.

Study groups in NCT00468572
Study groupRoleWhat they receive
1ExperimentalParticipants will receive treatment with affectionate writing
Receives: Behavioral: Affectionate Writing
2Active comparatorParticipants will receive treatment with meaningless writing
Receives: Behavioral: Meaningless Writing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Oxytocin levels

    Measured: Measured at Hour 2

  2. Cortisol levels

    Measured: Measured at Hour 2

Secondary outcomes (1)
  1. Self-reported stress level

    Measured: Measured at Hour 2

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 May 2007 (estimated)
  2. Study startFeb 2007
  3. Primary completionDec 2007
  4. Study completionDec 2007

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00468572
Sponsor's protocol ID
R03MH075757
Other IDs
R03MH075757, DATR A2-A1A
Status last verified
Jan 2012
First submitted
1 May 2007
Last updated
10 Jan 2012
Results posted
No
Data monitoring committee
No

Publications

  • Floyd K, Mikkelson AC, Tafoya MA, Farinelli L, La Valley AG, Judd J, Haynes MT, Davis KL, Wilson J. Human affection exchange: XIII. Affectionate communication accelerates neuroendocrine stress recovery. Health Commun. 2007;22(2):123-32. doi: 10.1080/10410230701454015.

    PubMed 17668992

Questions about this trial

What is this clinical trial studying?

A study testing Affectionate Writing and Meaningless Writing in people with Stress, run by Arizona State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Jan 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Oxytocin levels (time frame: Measured at Hour 2). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00468572, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jan 2012.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in